R. Macias

Metabolic-associated fatty liver disease: from simple steatosis towards liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, endorsed by the Spanish Association for the Study of the Liver (AEEH)

J. Falcón-Pérez, J. Ampuero, M. Fernández-Barrena, 2022, Gastroenterologia y hepatologia.

Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.

Z. Sparchez, A. Forner, M. Krawczyk, 2021, Journal of hepatology.

Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System

A. Forner, M. Krawczyk, C. Braconi, 2020, Hepatology.

Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma

T. Karlsen, M. Krawczyk, M. Vesterhus, 2023, Journal of hepatology.

Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis

C. Braconi, V. Cardinale, A. Lamarca, 2023, Cells.

Metabolic-associated fatty liver disease: from simple steatosis towards liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, endorsed by the Spanish Association for the Study of the Liver (AEEH)

J. Falcón-Pérez, J. Ampuero, M. Fernández-Barrena, 2022, Gastroenterología y Hepatología.

The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment

L. Rimassa, A. Lamarca, R. Macias, 2023, Hepatobiliary surgery and nutrition.